Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 18 von 125072

Details

Autor(en) / Beteiligte
Titel
KIOM-79 inhibits high glucose or AGEs-induced VEGF expression in human retinal pigment epithelial cells
Ist Teil von
  • Journal of ethnopharmacology, 2007-05, Vol.112 (1), p.166-172
Ort / Verlag
Shannon: Elsevier Ireland Ltd
Erscheinungsjahr
2007
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
  • We evaluated whether KIOM-79, a mixture of extracts obtained from Puerariae lobata, Magnolia officinalis, Glycyrrhiza uralensis and Euphorbia pekinensis, could inhibit vascular endothelial growth factor (VEGF) expression in human retinal pigment epithelial (RPE) cells cultured under high glucose (HG, 25 mM) or S100b (a specific ligand of the receptor for advance glycation end products (RAGE), 5 μg/ml). In this study, the effect of KIOM-79 on HG or S100b-induced VEGF expression was investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, RT-PCR, ELISA, and Western blot on human RPE cells. The MTT assay ( p < 0.01) revealed that KIOM-79 (up to 1 mg/ml) had no effect on cell growth. HG or S100b induced an increase in expression of VEGF at both mRNA and protein levels ( p < 0.05; p < 0.01 versus control). The increase in VEGF expression by HG or S100b was dose- and time-dependently prevented by KIOM-79 ( p < 0.05 versus 25 mM glucose; p < 0.01 versus S100b). Also, KIOM-79 inhibited protein kinase C (PKC)-α/β α and p38 mitogen-activated protein kinase (MAPK) activation. Our results demonstrate that KIOM-79 can inhibit VEGF expression via inhibition of the MAPK and PKC pathway.
Sprache
Englisch
Identifikatoren
ISSN: 0378-8741
eISSN: 1872-7573
DOI: 10.1016/j.jep.2007.02.017
Titel-ID: cdi_proquest_miscellaneous_70487876
Format
Schlagworte
bioassays, Biological and medical sciences, Blotting, Western, cell growth, Cells, Cultured, chemical constituents of plants, Diabetic retinopathy, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme-Linked Immunosorbent Assay, epithelial cells, Epithelial Cells - metabolism, Euphorbia, Euphorbia pekinensis, General pharmacology, Glucose - pharmacology, Glycation End Products, Advanced - metabolism, Glycyrrhiza uralensis, High glucose, human cell lines, Humans, hyperglycemia, KIOM-79, Ligands, Magnolia, Magnolia officinalis, Medical sciences, medicinal plants, medicinal properties, Nerve Growth Factors - pharmacology, p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors, p38 Mitogen-Activated Protein Kinases - metabolism, Pharmacognosy. Homeopathy. Health food, Pharmacology. Drug treatments, Pigment Epithelium of Eye - drug effects, Pigment Epithelium of Eye - metabolism, plant extracts, Plant Extracts - pharmacology, Protein Kinase C - antagonists & inhibitors, Protein Kinase C - metabolism, Pueraria montana var. lobata, Receptor for Advanced Glycation End Products, Receptors, Immunologic - metabolism, retina, Retinal pigment epithelial cells, Reverse Transcriptase Polymerase Chain Reaction, RNA, Messenger - biosynthesis, S100 Calcium Binding Protein beta Subunit, S100 Proteins - pharmacology, S100b, Vascular endothelial growth factor, Vascular Endothelial Growth Factor A - antagonists & inhibitors, Vascular Endothelial Growth Factor A - biosynthesis, vascular endothelial growth factors

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX